Jiangsu Hengrui Pharmaceuticals Co.,Ltd (SHA:600276)

SHA:600276 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	398,482	291,858	287,598	245,741	323,076	591,745
Market Cap Growth	29.83%	1.48%	17.03%	-23.94%	-45.40%	53.53%
Enterprise Value	358,617	269,604	270,642	228,393	306,010	576,180
Last Close Price	60.00	45.73	44.85	38.07	49.91	91.20
PE Ratio	51.71	46.06	66.85	62.91	71.32	93.51
Forward PE	39.27	49.34	56.94	49.45	52.14	85.65
PS Ratio	12.86	10.43	12.60	11.55	12.47	21.34
PB Ratio	6.64	6.33	7.01	6.40	9.08	19.22
P/TBV Ratio	6.86	6.58	7.27	6.59	9.35	19.62
P/FCF Ratio	40.71	53.52	46.69	-	126.49	205.64
P/OCF Ratio	33.35	39.32	37.63	194.22	76.58	172.42
PEG Ratio	-	4.11	3.47	10.27	4.78	3.53
EV/Sales Ratio	11.57	9.63	11.86	10.74	11.81	20.78
EV/EBITDA Ratio	41.58	37.48	55.89	63.46	71.83	85.74
EV/EBIT Ratio	45.90	41.63	64.81	74.65	81.29	91.87
EV/FCF Ratio	36.64	49.44	43.94	-	119.81	200.23
Debt / Equity Ratio	0.00	0.00	0.00	0.04	0.00	-
Debt / EBITDA Ratio	0.01	0.02	0.02	0.37	0.04	-
Debt / FCF Ratio	0.01	0.02	0.01	-	0.06	-
Asset Turnover	0.53	0.60	0.53	0.52	0.70	0.89
Inventory Turnover	1.61	1.64	1.50	1.44	1.80	1.98
Quick Ratio	5.95	8.62	10.74	7.36	7.72	6.70
Current Ratio	6.55	9.72	12.25	8.50	8.88	7.44
Return on Equity (ROE)	14.34%	14.55%	10.77%	10.31%	13.51%	22.64%
Return on Assets (ROA)	8.37%	8.62%	6.06%	4.69%	6.36%	12.59%
Return on Capital (ROIC)	9.34%	9.27%	6.45%	5.07%	7.07%	14.07%
Return on Capital Employed (ROCE)	12.90%	13.90%	10.10%	7.90%	10.50%	20.30%
Earnings Yield	1.87%	2.17%	1.50%	1.59%	1.40%	1.07%
FCF Yield	2.46%	1.87%	2.14%	-0.30%	0.79%	0.49%
Dividend Yield	0.33%	0.44%	0.45%	0.42%	0.32%	0.18%
Payout Ratio	17.06%	20.12%	23.77%	26.00%	23.54%	16.07%
Buyback Yield / Dilution	-1.59%	-0.15%	1.20%	-0.36%	0.18%	0.03%
Total Shareholder Return	-1.26%	0.29%	1.65%	0.06%	0.50%	0.21%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.